Stock listing
CGS Stock Price, News, Filings & Events — Cogstate Ltd
Selected listing: CGS · ASX · AUD · AU
This page tracks Cogstate Ltd's CGS:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGS:ASX. CGS:ASX is the stock-level entry point for investors researching Cogstate Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cogstate Ltd is a public company listed on the Australian market under the ticker CGS, with a market capitalization of approximately AUD 305.46 million. The company specializes in cognitive assessment technology, providing solutions for clinical trials and healthcare settings. Cogstate aims to enhance the understanding of cognitive function through its innovative products and services.

- Ticker
- CGS:ASX
- Asset type
- Stock
- Market cap
- $391.2M
- Sector
- Commercial Services
- Industry
- Miscellaneous Commercial Services
- Exchange
- ASX
- Currency
- AUD
Cogstate Ltd CGS:ASX stock context
This page tracks Cogstate Ltd's CGS:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following CGS:ASX. CGS:ASX is the stock-level entry point for investors researching Cogstate Ltd, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Cogstate Ltd is a public company listed on the Australian market under the ticker CGS, with a market capitalization of approximately AUD 305.46 million. The company specializes in cognitive assessment technology, providing solutions for clinical trials and healthcare settings. Cogstate aims to enhance the understanding of cognitive function through its innovative products and services.
Latest news from Cogstate Ltd
Cogstate Ltd earnings calls
Research Cogstate Ltd
Cogstate Ltd investor report
Review AI stock analysis and investor report context for CGS:ASX.
Cogstate Ltd company profile
View the public company page for Cogstate Ltd on 6ix.
Cogstate Ltd news
Read company news and market updates connected to Cogstate Ltd.
Cogstate Ltd investor events
Find investor webinars, events, and replay context for Cogstate Ltd.
Alternate listings
COGZF:OTC
US · USD
Alternate listing for Cogstate Ltd; the primary context on this page is CGS:ASX.
C4B:GETTEX
DE · EUR
Alternate listing for Cogstate Ltd; the primary context on this page is CGS:ASX.
A0ESLQ:LSX
DE · EUR
Alternate listing for Cogstate Ltd; the primary context on this page is CGS:ASX.
C4B:FWB
DE · EUR
Alternate listing for Cogstate Ltd; the primary context on this page is CGS:ASX.
C4B:MUN
DE · EUR
Alternate listing for Cogstate Ltd; the primary context on this page is CGS:ASX.
A0ESLQ:LS
DE · EUR
Alternate listing for Cogstate Ltd; the primary context on this page is CGS:ASX.